article_metadata: Jieqiong Peng Qiang Zhu Ziru Peng Zhen Chen Yuantao Liu Bo Liu
article_metadata: 10.3389/fimmu.2022.1049518
article_metadata: Front Immunol
article_metadata: 2022 Dec 8;13:1049518.
article_metadata: ak104/cadonilimab her-2 positive pd-1/ctla-4 bispecific advanced gastroesophageal junction cancer complete response
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36569905/
article_metadata: Esophageal Neoplasms / drug therapy Esophageal Neoplasms / pathology Hepatitis / pathology Stomach Neoplasms / drug therapy Stomach Neoplasms / genetics Stomach Neoplasms / metabolism
article_metadata: Esophageal Neoplasms / drug therapy Esophageal Neoplasms / pathology Hepatitis / pathology Stomach Neoplasms / drug therapy Stomach Neoplasms / genetics Stomach Neoplasms / metabolism Case Reports Research Support, Non-U.S. Gov't Adult CTLA-4 Antigen Esophagogastric Junction / pathology Humans Male Positron Emission Tomography Computed Tomography Programmed Cell Death 1 Receptor Programmed Cell Death 1 Receptor CTLA-4 Antigen
article_metadata: PMC9773983
article_metadata: 36569905
article_metadata: Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104/cadonilimab (PD-1/CTLA-4 bispecific): A case report
article_metadata: 2022